Kenneth J. Hillan

Insider Reports History

Location
Richmond, CA
Signature
/s/ Prathyusha Duraibabu, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth J. Hillan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
23andMe Holding Co. Chief Therapeutics Officer Class A Common Stock 222K $159K $0.72 05 Jun 2023 Direct
SANGAMO THERAPEUTICS, INC Director Common Stock 99.6K $45.8K $0.46 12 Jun 2025 Direct
SANGAMO THERAPEUTICS, INC Director Stock Option (Right to Buy) 50K 12 Jun 2025 Direct
Zymeworks Inc. Director Stock Option (Right to Buy) 37K 07 Dec 2023 Direct
Zymeworks Inc. Director Stock Option (Right to Buy) 9K 06 May 2021 Direct

Insider Reports Filed by Kenneth J. Hillan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMO SANGAMO THERAPEUTICS, INC 12 Jun 2025 2 $0 4 Director 16 Jun 2025, 16:05
SGMO SANGAMO THERAPEUTICS, INC 04 Jun 2024 2 $0 4 Director 06 Jun 2024, 16:23
ZYME Zymeworks Inc. 07 Dec 2023 1 $0 4 Director 08 Dec 2023, 17:17
ME 23andMe Holding Co. 05 Jun 2023 2 -$31.9K 4 Chief Therapeutics Officer 07 Jun 2023, 16:20
SGMO SANGAMO THERAPEUTICS, INC 01 Jun 2023 2 $0 4 Director 05 Jun 2023, 16:48
ME 23andMe Holding Co. 20 May 2023 1 -$8.98K 4 Chief Therapeutics Officer 23 May 2023, 16:05
ME 23andMe Holding Co. 20 Feb 2023 1 -$15.7K 4 Chief Therapeutics Officer 22 Feb 2023, 16:12
ZYME Zymeworks Inc. 21 Dec 2022 1 $0 4 Director 23 Dec 2022, 18:00
ME 23andMe Holding Co. 20 Nov 2022 1 -$13.8K 4 Chief Therapeutics Officer 22 Nov 2022, 15:11
ME 23andMe Holding Co. 24 Aug 2022 1 -$31.9K 4 Chief Therapeutics Officer 25 Aug 2022, 17:00
ME 23andMe Holding Co. 20 Aug 2022 1 -$15.4K 4 Chief Therapeutics Officer 22 Aug 2022, 18:12
ME 23andMe Holding Co. 01 Jun 2022 1 -$13K 4 Chief Therapeutics Officer 02 Jun 2022, 16:26
SGMO SANGAMO THERAPEUTICS, INC 25 Feb 2022 2 $0 4 Director 01 Mar 2022, 16:09
ME 23andMe Holding Co. 09 Feb 2022 2 $0 4 Head of Therapeutics 11 Feb 2022, 15:23
ME 23andMe Holding Co. 16 Jun 2021 0 $0 3 Head of Therapeutics 25 Jun 2021, 17:22
ZYME Zymeworks Inc. 06 May 2021 1 $0 4 Director 07 May 2021, 20:45